Dr. Mark T. Eginton, MD

Dr. Eginton practices at Sanford Fargo Hospice in Fargo, North Dakota.

Dr. Eginton's NPI, 1194776617, was assigned on May 12, 2006. Dr. Eginton graduated from University Of Minnesota Medical School in 1995. Dr. Eginton holds Minnesota license 45530.

Dr. Eginton's primary practice is Sanford Fargo Hospice, at 801 Broadway North, Fargo, ND 58102 in Cass County. The practice phone is (701) 234-7550.

Dr. Eginton's primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Dr. Eginton is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Eginton to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eginton practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Eginton's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Eginton is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Eginton's licenses on file in 3 states: Minnesota, North Dakota and Wisconsin.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Eginton treats.

CMS data shows 1,099 Medicare services from Dr. Eginton across 19 procedure codes in 2024, for 786 Medicare patients. Medicare paid $31,921 for them.

CMS counts 786 Medicare patients who saw Dr. Eginton in 2024. The largest group is 65 to 74, with 304 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eginton's median patient age at 74, with 45% women.

In 2024, Dr. Eginton wrote 59 Medicare Part D claims for 33 patients. 92% of them were for generic drugs. CMS names the drug for 39 of them, across 2 drugs with 11 or more claims each, at $456 in total drug cost. In 2023, CMS named 72 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Eginton for performance year 2024, reported as part of a group. Dr. Eginton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 426 procedures of removal of tissue by Dr. Eginton, more than 96% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Eginton in 2003. Dr. Eginton has published most often in Ann Vasc Surg. Dr. Eginton's most frequent co-authors are Joseph Patrick Hart, MD and Brian D. Lewis, MD.

CMS Open Payments shows 81 general payments to Dr. Eginton from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Medtronic Vascular, Inc. paid the most, $2,626.

Dmand AI lists 2 awards for Dr. Eginton, most recently CMS Stage 1 EHR in 2013.

Dr. Eginton graduated from University Of Minnesota Medical School in 1995. Dr. Eginton is a member of ACS and SVS.

Dr. Eginton is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.